An in vitro assay for evaluation of small-molecule inhibitors of cholesterol absorption

Angewandte Chemie - International Edition

Volumn 43, Issue 35, 2004, Pages 4653-4656

  Kværnø, Lisbet ^a   Ritter, Tobias ^a   Werder, Moritz ^a   Hauser, Helmut ^a   Carreira, Erick M ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Cholesterol; Inhibitors; Medicinal chemistry; Membranes

Indexed keywords

ABSORPTION; ASSAYS; CHOLESTEROL; ENZYME INHIBITION; GLYCOLS;

HYDROLYZATION; VITRO ASSAY; VITRO TESTING;

MACROMOLECULES;

BETA LACTAM; CAVEOLIN 1; CELLOBIOSE; CHOLESTEROL; EZETIMIBE; GLUCOSIDE; GLUCURONIDE; LIPOCORTIN 2; SCAVENGER RECEPTOR;

ARTICLE; CHOLESTEROL TRANSPORT; HUMAN; IN VITRO STUDY; INTESTINE BRUSH BORDER MEMBRANE; LIPID ABSORPTION; MITSUNOBU REACTION; NONHUMAN;

ABSORPTION; ANIMALS; CHOLESTEROL; CRICETINAE; GLYCOSIDES; HYDROLYSIS; MOLECULAR STRUCTURE;

EID: 5344243182     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200460348     Document Type: Article

References (46)

1. Heart Disease and Stroke. Statistics - 2003 Update. Available from The American Heart Association at: http://www.americanheart.org/downloadable/heart/ 10590179711482003HDSStatsBookREV7-03.pdf.
2. T. Sudhop, K. von Bergmann, Drugs 2002, 62, 2333.
3. E. Bruckert, Cardiology 2002, 97, 59.
4. D. J. Maron, S. Fazio, M. F. Linton, Circulation 2000, 101, 207.
5. Euroaspire II Study Group, Eur. Heart J. 2001, 22, 554.
6. a) FDA Drug Approvals List [online]: http://www.fda.gov/cder/foi/label/ 2002/214451b1.pdf;
7. b) J. W. Clader, J. Med. Chem. 2004, 47, 1;
8. c) S. B. Rosenblum, T. Huynh, A. Afonso, H. R. Davis, N. Yumibe, J. W. Clader, D. A. Burnett, J. Med. Chem. 1998, 41, 973.
9. a) H. Thurnhofer, H. Hauser, Biochemistry 1990, 29, 2142;
10. b) S. Compassi, M. Werder, D. Boffelli, F. E. Weber, H. Hauser, G. Schulthess, Biochemistry 1995, 34, 16473;
11. c) S. Compassi, M. Werder, F. E. Weber, D. Boffeli, H. Hauser, Biochemistry 1997, 36, 6643;
12. d) G. Schulthess, S. Compassi, D. Boffelli, M. Werder, F. E. Weber, H. Hauser, J. Lipid Res. 1996, 37, 2405;
13. e) H. Hauser, J. H. Dyer, A. Nandy, M. A. Vega, M. Werder, E. Bieliauskaite, F. E. Weber, S. Compassi, A. Gemperli, D. Boffelli, E. Wehrli, G. Schulthess, M. C. Phillips, Biochemistry 1998, 37, 17843;
14. f) M. Werder, C. H. Han, E. Wehrli, D. Bimmler, G. Schulthess, H. Hauser, Biochemistry 2001, 40, 11643.
15. a) S. F. Cai, R. J. Kirby, P. N. Howles, D. Y. Hui, J. Lipid Res. 2001, 42, 902;
16. b) L. Cai, E. R. M. Eckhardt, W. Shi, Z. Zhao, M. Nasser, W. J. S. de Villiers, D. R. van der Westhuyzen, J. Lipid Res. 2004, 45, 253;
17. c) S. W. Altmann, H. R. Davis, X. R. Yao, M. Laverty, D. S. Compton, L. J. Zhu, J. H. Crona, M. A. Caplen, L. M. Hoos, G. Tetzloff, T. Priestley, D. A. Burnett, C. D. Strader, M. P. Graziano, Biochim. Biophys. Acta 2002, 1580, 77;
18. d) E. Levy, D. Menard, I. Suc, E. Delvin, V. Marcil, L. Brissette, L. Thibault, M. Bendayan, J. Cell Sci. 2004, 117, 327;
19. e) D. Jourdheuil-Rahmani, M. Charbonnier, N. Domingo, F. Luccioni, H. Lafont, D. Lairon, Biochem. Biophys. Res. Commun. 2002, 292, 390;
20. f) B. Play, S. Salvini, Z. Haikal, M. Charbonnier, A. Harbis, M. Roussel, D. Lairon, D. Jourdheuil-Rahmani, Biochem. Biophys. Res. Commun. 2003, 310, 446.
21. A. van Bennekum, M. Werder, S. T. Thuahnai, C.-H. Han, D. L. Williams, P. Wettstein, G. Schulthess, M. C. Phillips, H. Hauser, Biochemistry 2004, submitted.
22. S. W. Altmann, H. R. Davis, L. J. Zhu, X. R. Yao, L. M. Hoos, G. Tetzloff, S. P. N. Iyer, M. Maguire, A. Golovko, M. Zeng, L. Q. Wang, N. Murgolo, M. P. Graziano, Science 2004, 303, 1201.
23. E. J. Smart, R. A. De Rose, S. A. Farber, Proc. Natl. Acad. Sci. USA 2004, 101, 3450.
24. H. Hauser, K. Howell, R. M. C. Dawson, D. E. Bowyer, Biochim. Biophys. Acta 1980, 602, 567.
25. [7e]
26. The incorporation into vesicles was shown to be quantitative for representative inhibitors by gel filtration of the vesicles according to established procedures (see G. Schulthess, S. Compassi, M. Werder, C. H. Han, M. C. Phillips, H. Hauser, Biochemistry 2000, 39, 12 623, and references therein) followed by reversed-phase HPLC analysis.
27. [7b]
28. G. Z. Wu, Y. S. Wong, X. Chen, Z. X. Ding, J. Org. Chem. 1999, 64, 3714.
29. M. Browne, D. A. Burnett, M. A. Caplen, 0L. Y. Chen, J. W. Clader, M. Domalski, S. Dugar, P. Pushpavanam, R. Sher, W. Vaccaro, M. Viziano, H. R. Zhao, Tetrahedron Lett. 1995, 36, 2555.
30. J. W. Clader, D. A. Burnett, M. A. Caplen, M. S. Domalski, S. Dugar, W. Vaccaro, R. Sher, M. E. Browne, H. R. Zhao, R. E. Burrier, B. Salisbury, H. R. Davis, J. Med. Chem. 1996, 39, 3684.
31. W. D. Vaccaro, H. R. Davis, Bioorg. Med. Chem. Lett. 1998, 8, 313.
32. a) D. A. Burnett, M. A. Caplen, H. R. Davis, R. E. Burrier, J. W. Clader, J. Med. Chem. 1994, 37, 1733;
33. b) R. Schnitzerpolokoff, D. Compton, G. Boykow, H. Davis, R. Burrier, Comp. Biochem. Physiol. Part A 1991, 99, 665.
34. a) A. M. Rouhi, Chem. Eng. News 2003, 81, 104;
35. for recent examples of successful molecular editing of epothilones, see: b) T. C. Chou, H. J. Dong, A. Rivkin, F. Yoshimura, A. E. Gabarda, Y. S. Cho, W. P. Tong, S. J. Danishefsky, Angew. Chem. 2003, 115, 4910; Angew. Chem. Int. Ed. 2003, 42, 4761; c) K. C. Nicolaou, P. K. Sasmal, G. Rassias, M. V. Reddy, K. H. Altmann, M. Wartmann, A. O'Brate, P. Giannakakou, Angew. Chem. 2003, 115, 3639; Angew. Chem. Int. Ed. 2003, 42, 3515.
36. for recent examples of successful molecular editing of epothilones, see: b) T. C. Chou, H. J. Dong, A. Rivkin, F. Yoshimura, A. E. Gabarda, Y. S. Cho, W. P. Tong, S. J. Danishefsky, Angew. Chem. 2003, 115, 4910; Angew. Chem. Int. Ed. 2003, 42, 4761; c) K. C. Nicolaou, P. K. Sasmal, G. Rassias, M. V. Reddy, K. H. Altmann, M. Wartmann, A. O'Brate, P. Giannakakou, Angew. Chem. 2003, 115, 3639; Angew. Chem. Int. Ed. 2003, 42, 3515.
37. for recent examples of successful molecular editing of epothilones, see: b) T. C. Chou, H. J. Dong, A. Rivkin, F. Yoshimura, A. E. Gabarda, Y. S. Cho, W. P. Tong, S. J. Danishefsky, Angew. Chem. 2003, 115, 4910; Angew. Chem. Int. Ed. 2003, 42, 4761; c) K. C. Nicolaou, P. K. Sasmal, G. Rassias, M. V. Reddy, K. H. Altmann, M. Wartmann, A. O'Brate, P. Giannakakou, Angew. Chem. 2003, 115, 3639; Angew. Chem. Int. Ed. 2003, 42, 3515.
38. for recent examples of successful molecular editing of epothilones, see: b) T. C. Chou, H. J. Dong, A. Rivkin, F. Yoshimura, A. E. Gabarda, Y. S. Cho, W. P. Tong, S. J. Danishefsky, Angew. Chem. 2003, 115, 4910; Angew. Chem. Int. Ed. 2003, 42, 4761; c) K. C. Nicolaou, P. K. Sasmal, G. Rassias, M. V. Reddy, K. H. Altmann, M. Wartmann, A. O'Brate, P. Giannakakou, Angew. Chem. 2003, 115, 3639; Angew. Chem. Int. Ed. 2003, 42, 3515.
39. M. van Heek, C. Farley, D. S. Compton, L. Hoos, K. B. Alton, E. J. Sybertz, H. R. Davis, Br. J. Pharmacol. 2000, 129, 1748.
40. W. D. Vaccaro, R. Sher, H. R. Davis, Bioorg. Med. Chem. Lett. 1998, 8, 35.
41. S. J. Spak, O. R. Martin, Tetrahedron 2000, 56, 217.
42. S. Dugar, M. P. Kirkup, J. W. Clader, S. I. Lin, R. Rizvi, M. E. Snow, H. R. Davis, S. W. McCombie, Bioorg. Med. Chem. Lett. 1995, 5, 2947.
43. B. A. Shinkre, V. G. Puranik, B. M. Bhawal, A. Deshmukh, Tetrahedron: Asymmetry 2003, 14, 453.
44. T. Kambara, K. Tomioka, J. Org. Chem. 1999, 64, 9282.
45. a) E. J. Corey, R. K. Bakshi, S. Shibata, J. Am. Chem. Soc. 1987, 109, 5551;
46. b) E. J. Corey, R. K. Bakshi, S. Shibata, C. P. Chen, V. K. Singh, J. Am. Chem. Soc. 1987, 109, 7925.